Matches in SemOpenAlex for { <https://semopenalex.org/work/W2064426938> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W2064426938 endingPage "104" @default.
- W2064426938 startingPage "96" @default.
- W2064426938 abstract "We performed a double-blind, randomised controlled trial to evaluate the results of ultrasound-guided aspiration of endometriomas under the effect of GnRH analogues and a possible additional beneficial effect by leaving 600000 IU of recombinant interleukin-2 (rIL-2) in the cysts. Twenty-four women with endometriosis-related symptoms, increased values of CA-125 and transvaginal ultrasonography showing endometriomas >3 cm who were initially sent to us for laparotomy and conservative surgery for endometriosis were included. Main outcome measures were severity of symptoms, size and percentage of echographical reduction of endometriomas and CA-125 levels after 2 menses post-GnRH analogues. Secondary outcome measures were the time until recurrence of abnormal parameters and the need for surgery after treatment. We found moderate clinical results after treatment with drainage plus GnRH analogues and significantly improved results in women having received rIL-2 intracystically. There were no side effects. Two out of 3 previously infertile patients became pregnant after therapy. Though the rates of recurrence of endometriomas >or=3 cm were similar in both groups, the period until recurrence was significantly greater when rIL-2 was used, and the rates of recurrence of symptoms and increased CA-125 values were also significantly lower in patients who received rIL-2. Surgery was finally performed on 10 patients (4 with and 6 without previous rIL-2 treatment) during follow-up (30 +/- 12.7 months). These findings led to the conclusion that transvaginal ultrasound-guided puncture and aspiration of endometriomas under endometrial suppressive therapy with GnRH analogues have some value for endometriosis treatment, improving the clinical manifestations and avoiding some surgical therapies, and that rIL-2 left in the cyst increases these beneficial effects significantly." @default.
- W2064426938 created "2016-06-24" @default.
- W2064426938 creator A5013078275 @default.
- W2064426938 creator A5014819700 @default.
- W2064426938 creator A5021120907 @default.
- W2064426938 creator A5056781848 @default.
- W2064426938 creator A5069161740 @default.
- W2064426938 date "2003-01-01" @default.
- W2064426938 modified "2023-09-30" @default.
- W2064426938 title "GnRH Analogues, Transvaginal Ultrasound-Guided Drainage and Intracystic Injection of Recombinant Interleukin-2 in the Treatment of Endometriosis" @default.
- W2064426938 cites W2019630312 @default.
- W2064426938 cites W2114685431 @default.
- W2064426938 cites W2144504916 @default.
- W2064426938 cites W2152421826 @default.
- W2064426938 cites W2169295630 @default.
- W2064426938 doi "https://doi.org/10.1159/000070181" @default.
- W2064426938 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12771456" @default.
- W2064426938 hasPublicationYear "2003" @default.
- W2064426938 type Work @default.
- W2064426938 sameAs 2064426938 @default.
- W2064426938 citedByCount "40" @default.
- W2064426938 countsByYear W20644269382012 @default.
- W2064426938 countsByYear W20644269382013 @default.
- W2064426938 countsByYear W20644269382014 @default.
- W2064426938 countsByYear W20644269382015 @default.
- W2064426938 countsByYear W20644269382016 @default.
- W2064426938 countsByYear W20644269382017 @default.
- W2064426938 countsByYear W20644269382018 @default.
- W2064426938 countsByYear W20644269382020 @default.
- W2064426938 countsByYear W20644269382021 @default.
- W2064426938 countsByYear W20644269382022 @default.
- W2064426938 countsByYear W20644269382023 @default.
- W2064426938 crossrefType "journal-article" @default.
- W2064426938 hasAuthorship W2064426938A5013078275 @default.
- W2064426938 hasAuthorship W2064426938A5014819700 @default.
- W2064426938 hasAuthorship W2064426938A5021120907 @default.
- W2064426938 hasAuthorship W2064426938A5056781848 @default.
- W2064426938 hasAuthorship W2064426938A5069161740 @default.
- W2064426938 hasConcept C126838900 @default.
- W2064426938 hasConcept C126894567 @default.
- W2064426938 hasConcept C141071460 @default.
- W2064426938 hasConcept C143753070 @default.
- W2064426938 hasConcept C2779522080 @default.
- W2064426938 hasConcept C2780778865 @default.
- W2064426938 hasConcept C29456083 @default.
- W2064426938 hasConcept C71924100 @default.
- W2064426938 hasConceptScore W2064426938C126838900 @default.
- W2064426938 hasConceptScore W2064426938C126894567 @default.
- W2064426938 hasConceptScore W2064426938C141071460 @default.
- W2064426938 hasConceptScore W2064426938C143753070 @default.
- W2064426938 hasConceptScore W2064426938C2779522080 @default.
- W2064426938 hasConceptScore W2064426938C2780778865 @default.
- W2064426938 hasConceptScore W2064426938C29456083 @default.
- W2064426938 hasConceptScore W2064426938C71924100 @default.
- W2064426938 hasIssue "2" @default.
- W2064426938 hasLocation W20644269381 @default.
- W2064426938 hasLocation W20644269382 @default.
- W2064426938 hasOpenAccess W2064426938 @default.
- W2064426938 hasPrimaryLocation W20644269381 @default.
- W2064426938 hasRelatedWork W2047967234 @default.
- W2064426938 hasRelatedWork W2141170103 @default.
- W2064426938 hasRelatedWork W2356476264 @default.
- W2064426938 hasRelatedWork W2360993163 @default.
- W2064426938 hasRelatedWork W2365549870 @default.
- W2064426938 hasRelatedWork W2367865101 @default.
- W2064426938 hasRelatedWork W2375032663 @default.
- W2064426938 hasRelatedWork W2390961722 @default.
- W2064426938 hasRelatedWork W2439875401 @default.
- W2064426938 hasRelatedWork W3112851427 @default.
- W2064426938 hasVolume "55" @default.
- W2064426938 isParatext "false" @default.
- W2064426938 isRetracted "false" @default.
- W2064426938 magId "2064426938" @default.
- W2064426938 workType "article" @default.